Firazyr (icatibant)

Details

Generic Name:
icatibant
Project Status:
Not filed
Manufacturer:
Takeda Canada Inc.
Brand Name:
Firazyr
Project Line:
Reimbursement Review
Project Number:
N/A
Submission Type:
Non Submission
Indications:
Acute attacks of hereditary angioedema in adolescents and children aged two years and older with C1-esterase inhibitor deficiency
Recommendation Type:
CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer